Trial of Meropenem Versus Piperacillin-Tazobactam on Mortality and Clinial Response

Clinical trial NCT02437045 · COMPLETED

Trial details

NCT number: NCT02437045
Sponsor: The University of Queensland
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bloodstream Infections

Start date: 2015-04-01
Primary completion: 2020-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.